Nanobiotix S.A. (NBTX) Financials

$5.80

$0.71 (13.95%)
Last update: 04:00 PM EST
Day's range
$4.93
Day's range
$5.86
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning20182018201920192020202020212021202220222023202320242024100000%100000%0%0%-100000%-100000%-200000%-200000%-300000%-300000%-400000%-400000%-500000%-500000%Profit Margin
Profit Margin
Revenue
Earnings

NBTX Income statement / Annual

Last year (2024), Nanobiotix S.A.'s total revenue was -$11.61 M, a decrease of 132.06% from the previous year. In 2024, Nanobiotix S.A.'s net income was -$68.13 M. See Nanobiotix S.A.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue -$11.61 M $36.21 M $4.78 M $10.00 K $50.00 K $68.00 K $116.00 K $251.97 K $1.56 M $265.54 K
Cost of Revenue $0.00 $0.00 $985.00 K $0.00 $0.00 $0.00 $0.00 $345.59 K $436.31 K $359.61 K
Gross Profit -$11.61 M $36.21 M $3.79 M $10.00 K $50.00 K $68.00 K $116.00 K -$93.62 K $1.12 M -$94.07 K
Gross Profit Ratio 1 1 0.79 1 1 1 1 -0.37 0.72 -0.35
Research and Development Expenses $40.54 M $38.40 M $32.64 M $30.38 M $24.33 M $30.41 M $20.89 M $16.34 M $16.92 M $13.90 M
General & Administrative Expenses $20.06 M $21.66 M $17.48 M $19.43 M $14.27 M $18.64 M $12.62 M $12.34 M $10.26 M $7.19 M
Selling & Marketing Expenses $0.00 $388.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $20.06 M $22.05 M $17.48 M $19.43 M $14.27 M $18.64 M $12.62 M $12.34 M $10.26 M $7.19 M
Other Expenses -$3.82 M $2.54 M -$3.41 M -$2.64 M -$2.07 M -$2.20 M -$3.33 M -$337.89 K $160.23 K $0.00
Operating Expenses $56.78 M $62.99 M $46.70 M $47.18 M $36.53 M $46.85 M $30.18 M $25.52 M $23.41 M $17.41 M
Cost And Expenses $56.78 M $62.99 M $46.70 M $47.18 M $36.53 M $46.85 M $30.18 M $25.52 M $23.41 M $17.41 M
Interest Income $2.63 M $1.22 M $256.00 K $6.17 M $4.68 M $105.00 K $34.00 K $33.03 K $59.49 K $183.22 K
Interest Expense $8.09 M $7.98 M $5.84 M $590.00 K $333.00 K $4.79 M $847.00 K $108.37 K $102.20 K $59.52 K
Depreciation & Amortization $1.62 M $551.00 K $1.50 M $1.56 M $1.76 M $1.77 M $569.00 K $345.59 K $436.31 K $456.08 K
EBITDA -$58.32 M -$23.69 M -$45.15 M -$45.61 M -$31.49 M -$44.78 M -$29.33 M -$25.55 M -$21.21 M -$16.49 M
EBITDA Ratio 5.02 -0.65 -9.45 -4560.5 -629.88 -658.46 -252.83 -101.39 -13.61 -62.09
Operating Income Ratio 5.89 -0.74 -9.78 -5257.9 -728.56 -687.93 -259.2 -100.28 -14.03 -64.55
Total Other Income/Expenses Net $361.00 K -$12.80 M -$10.33 M $5.58 M $2.85 M -$4.13 M -$278.00 K -$876.00 K $64.61 K $138.56 K
Income Before Tax -$68.03 M -$39.58 M -$57.03 M -$47.00 M -$33.61 M -$50.91 M -$30.35 M -$26.14 M -$21.79 M -$17.00 M
Income Before Tax Ratio 5.86 -1.09 -11.94 -4699.9 -672.28 -748.71 -261.59 -103.76 -13.99 -64.03
Income Tax Expense $101.00 K $120.00 K $10.00 K $5.00 K $9.00 K $3.00 K -$449.00 K $20.00 $90.43 K $37.58 K
Net Income -$68.13 M -$39.70 M -$57.04 M -$47.00 M -$33.62 M -$50.92 M -$29.90 M -$26.14 M -$21.88 M -$17.00 M
Net Income Ratio 5.87 -1.1 -11.94 -4700.4 -672.46 -748.75 -257.72 -103.76 -14.04 -64.03
EPS -1.44 -1.08 -1.64 -1.35 -1.38 -2.35 -1.52 -1.5 -1.43 -1.2
EPS Diluted -1.44 -1.08 -1.64 -1.35 -1.38 -2.35 -1.52 -1.5 -1.43 -1.2
Weighted Average Shares Out $47.27 M $36.76 M $34.85 M $34.73 M $24.39 M $21.63 M $19.62 M $17.43 M $15.28 M $14.14 M
Weighted Average Shares Out Diluted $47.27 M $36.93 M $34.85 M $34.73 M $24.39 M $21.63 M $19.63 M $17.48 M $15.28 M $14.14 M
Link